新生儿外源性白蛋白的临床使用研究进展
Clinical Application and Research Progress of Exogenous Albumin in Neonates
摘要: 白蛋白是血浆中含量最丰富的蛋白质之一，具有多种重要功能。新生儿血清白蛋白浓度随胎龄和出生后年龄变化较大。由于合成减少、白蛋白损失增加或重新分布至血管外间隙而发生低白蛋白血症，并与发病率和死亡率增加相关，因此，外源性白蛋白输注是数种新生儿疾病的抢救措施之一。但白蛋白输注可能启动高度复杂的过程，新生儿是特殊人群，在白蛋白的输注方面尚存在争议，但目前研究甚少，本文对新生儿临床使用白蛋白现状及相关进展进行综述。
Abstract: Albumin is one of the most abundant proteins in plasma and has a variety of important functions. Neonatal serum albumin concentrations vary greatly with gestational age and postnatal age. As hypoalbuminemia occurs due to decreased synthesis, increased albumin loss, or redistribution to the extravascular space and is associated with increased morbidity and mortality, exogenous albumin infusion is one of the rescue measures for several neonatal diseases. However, albumin infusion may initiate a highly complex process, newborns are special populations, and there is still controversy in the infusion of albumin, but there are few studies at present, and this article reviews the current status and related progress in the clinical use of albumin in newborns.
文章引用：张媛, 韦红. 新生儿外源性白蛋白的临床使用研究进展[J]. 临床医学进展, 2021, 11(5): 2088-2093. https://doi.org/10.12677/ACM.2021.115299

参考文献

[1] Nicholson, J.P., Wolmarans, M.R. and Park, G.R. (2000) The Role of Albumin in Critical Illness. British Journal of Anaesthesia, 85, 599-610. [Google Scholar] [CrossRef] [PubMed]
[2] Caraceni, P., Domenicali, M., Tovoli, A., Napoli, L., Serena Ricci, C., Tufoni, M., et al. (2013) Clinical Indications for the Albumin Use: Still a Controversial Issue. European Journal of Internal Medicine, 24, 721-728. [Google Scholar] [CrossRef] [PubMed]
[3] Oca, M.J., Nelson, M. and Donn, S.M. (2003) Randomized Trial of Normal Saline versus 5% Albumin for the Treatment of Neonatal Hypotension. Journal of Perinatology, 23, 473-476. [Google Scholar] [CrossRef] [PubMed]
[4] Barr, P.A., Bailey, P.E., Sumners, J. and Cassady, G. (1977) Relation between Arterial Blood Pressure and Blood Volume and Effect of Infused Albumin in Sick Preterm Infants. Pediatrics, 60, 282-289.
[5] Pladys, P., Wodey, E., Bétrémieux, P., Beuchée, A. and Ecoffey, C. (1997) Effects of Volume Expansion on Cardiac Output in the Preterm Infant. Acta Paediatrica, 86, 1241-1245. [Google Scholar] [CrossRef] [PubMed]
[6] Lynch, S.K., Mullett, M.D., Graeber, J.E. and Polak, M.J. (2008) A Comparison of Albumin-Bolus Therapy versus Normal Saline-Bolus Therapy for Hypotension in Neonates. Journal of Perinatology, 28, 29-33. [Google Scholar] [CrossRef] [PubMed]
[7] 曹慧萍. 早产儿出生体重与血白蛋白相关性分析[J]. 淮海医药, 2011, 29(5): 446.
[8] Cartlidge, P.H. and Rutter, N. (1986) Serum Albumin Concentrations and Oedema in the Newborn. Archives of Disease in Childhood, 61, 657-660. [Google Scholar] [CrossRef] [PubMed]
[9] So, K.W., Fok, T.F., Ng, P.C., Wong, W.W. and Cheung, K.L. (1997) Randomised Controlled Trial of Colloid or Crystalloid in Hypotensive Preterm Infants. Archives of Disease in Childhood-Fetal and Neonatal Edition, 76, F43-F46. [Google Scholar] [CrossRef] 
[10] Bland, R.D., Clarke, T.L., Harden, L.B., Mayer, J.L., Ries, J.P., Madden, W.A., et al. (1973) Early Albumin Infusion to Infants at Risk for Respiratory Distress. Archives of Disease in Childhood, 48, 800-805. [Google Scholar] [CrossRef] [PubMed]
[11] Porto, B.S., Jorge, S.M. and de Assis, M.G. (2005) Exogenous Human Albumin Supplementation in Total Parenteral Nutrition of Critically Ill Newborns. Jornal de Pediatria, 81, 41-46. [Google Scholar] [CrossRef] [PubMed]
[12] Cashore, W.J. and Oh, W. (1982) Unbound Bilirubin and Kernicterus in Low-Birth-Weight Infants. Pediatrics, 69, 481-485.
[13] 李维维, 赖燕, 冯圣芳, 李亚, 何善辉. 蓝光照射联合白蛋白治疗新生儿黄疸的疗效分析[J]. 实用临床医药杂志, 2017, 21(1): 94-96.
[14] Maisels, M.J., Bhutani, V.K., Bogen, D., Newman, T.B., Stark, A.R. and Watchko, J.F. (2009) Hyperbilirubinemia in the Newborn Infant > or =35 Weeks’ Gestation: An Update with Clarifications. Pediatrics, 124, 1193-1198. [Google Scholar] [CrossRef] [PubMed]
[15] Church, J.T., Antunez, A.G., Dean, A., Matusko, N., Deatrick, K.B., Attar, M.A., et al. (2017) Evidence-Based Management of Chylothorax in Infants. Journal of Pediatric Surgery, 52, 907-912. [Google Scholar] [CrossRef] [PubMed]
[16] McCaffrey, J., Lennon, R. and Webb, N.J. (2016) The Non-Immunosuppressive Management of Childhood Nephrotic Syndrome. Pediatric Nephrology, 31, 1383-1402. [Google Scholar] [CrossRef] [PubMed]
[17] Biscoping, J. (2009) Therapy with Blood Components and Plasma Derivatives: The Current Cross-Sectional Guidelines. Der Anaesthesist, 58, Article No. 1083. [Google Scholar] [CrossRef] [PubMed]
[18] Kavvadia, V., Greenough, A., Dimitriou, G. and Hooper, R. (2000) Randomised Trial of Fluid Restriction in Ventilated Very Low Birthweight Infants. Archives of Disease in Childhood-Fetal and Neonatal Edition, 83, F91-F96. [Google Scholar] [CrossRef] 
[19] Bland, R.D., Clarke, T.L. and Harden, L.B. (1976) Rapid Infusion of Sodium Bicarbonate and Albumin into High-Risk Premature Infants Soon after Birth: A Controlled, Prospective Trial. American Journal of Obstetrics and Gynecology, 124, 263-267. [Google Scholar] [CrossRef] 
[20] Goldberg, R.N., Chung, D., Goldman, S.L. and Bancalari, E. (1980) The Association of Rapid Volume Expansion and Intraventricular Hemorrhage in the Preterm Infant. The Journal of Pediatrics, 96, 1060-1063. [Google Scholar] [CrossRef] 
[21] Pulimood, T.B. and Park, G.R. (2000) Debate: Albumin Administration Should Be Avoided in the Critically Ill. Critical Care, 4, Article No. 151. [Google Scholar] [CrossRef] [PubMed]

为你推荐